On-Demand Cell Line Development Webinars
-
Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery
6/3/2025
Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.
-
Fast Track Your Path To Commercialization
5/21/2025
Discover key strategies for scaling biologics from bench to pilot scale and learn how to overcome challenges in process development, including control of agitation, oxygen, CO₂, and nutrient supplementation.
-
Optimizing Biotherapeutic Protein Expression With CHO Vector Technology
5/19/2025
Review the development of a high-strength synthetic gene promoter that enhances titers while maintaining exceptional product quality and expression stability, to support more efficient biomanufacturing.
-
CLD To Upstream Optimization: Enhancing Biologics Quality, Productivity
4/30/2025
Explore how advanced cell line development and upstream processing strategies optimize both productivity and therapeutic effectiveness, ensuring the development of high-quality biologics.
-
Using Data To Revolutionize Intensified Cell Line Development
4/14/2025
Discover how N-1 perfusion and concentrated fed-batch can revolutionize biomanufacturing by exploring an advanced data analytics tool that simplifies early-stage upstream process optimization through in silico simulations.
-
Cell Line Development Tools For Rapid Prototyping
4/14/2025
Discover rapid prototyping tools for cell line development, optimize clone selection, and learn how modern technology reduces process risks to enhance your capabilities with the latest advancements.
-
Epitope Base Editing CD45 In Hematopoietic Cells Enables Universal Blood Cancer Immune Therapy
11/22/2024
Researchers developed base-edited CAR T cells and CD45-edited stem cells to create universal blood cancer immunotherapy, showcasing efficacy while minimizing toxicity using MaxCyte electroporation technology.
-
Unlocking The Potential Of Electroporation
11/22/2024
Electroporation enables genetic research by introducing material into cells, advancing disease modeling, gene therapy, and ion channel studies. MaxCyte technology offers scalable, efficient solutions for high-throughput applications.
-
Overcome The Limitations Of Conventional Transfection With Electroporation
11/22/2024
Learn how electroporation technology improves gene editing efficiency, reduces cell death, and enables scalable workflows for cell therapy, screening, and bioproduction in this informative webinar.
-
Manufacturing Strategies And Facility Design For Patient-Centric Delivery
11/21/2024
Review how to select the optimal manufacturing strategy and leverage technologies for efficient and scalable production of therapeutic proteins. De-risk the supply chain, accelerate time to market, and reduce costs.